It’s always a good idea to pay attention to insider buying. After all, it’s the insiders who know their company the best. And ...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...

Incyte Corporation (NASDAQ:INCY) is one of the 10 biotech stocks screaming a buy. On June 17, Incyte was a big mover in the ...

Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its annual Corporate Social Responsibility (CSR) Report. The report spotlights the ways ...

Caris Life Sciences is experiencing rapid growth, leveraging AI and molecular science for personalized medicine. Click here ...

The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

QIAGEN N.V. (QGEN) and Incyte (INCY) announced a collaboration to develop a new diagnostic panel that will support Incyte's experimental therapies for patients with myeloproliferative neoplasms (MPNs) ...

Saudi biotech startup Novo Genomics signed two major agreements: one with Tracer Biotechnologies to localize ctDNA monitoring ...

Grail (NASDAQ:GRAL) announced Wednesday that its Galleri test led to improved cancer detection when added to standard-of-care ...